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ABSTRACT This study was conducted to investigate the prevalence of and risk fac-
tors for colonization and acquisition of carbapenem-resistant (CR) Gram-negative
bacteria (GNB) among patients admitted to intensive care units (ICUs) in two tertiary
care hospitals in northern Thailand. Screening of rectal swab specimens for CR-GNB
was performed on patients at ICU admission and discharge. The phenotypes and ge-
notypes of all isolates were determined. Risk factors were analyzed by logistic re-
gression analysis. The overall carriage rate of CR-GNB at admission was 11.6% (32/
275), with the most predominant species carried being Acinetobacter baumannii (n 
15), followed by Klebsiella pneumoniae (n  9). The risk factor for CR-GNB coloniza-
tion was hospitalization within the previous 6 months (P  0.002). During the ICU
stay, the rate of CR-GNB acquisition was 25.2% (52/206), with the most predominant
species carried being A. baumannii (n  28) and K. pneumoniae (n  13). Risk factors
associated with CR-GNB acquisition were the use of an enteral feeding tube (P 
0.008) and administration of third-generation cephalosporins (P  0.032) and car-
bapenems (P  0.045). The most common carbapenemase genes in A. baumannii
and K. pneumoniae were blaOXA-23/51 and blaNDM, respectively. Patient-to-patient
transmission was demonstrated in three cases, resulting in the acquisition of CR A.
baumannii (2 cases) and K. pneumoniae (1 case) isolates from other patients who
were admitted during the same period of time. This is the ﬁrst Indochinese study
screening patients, examining patients for the carriage of CR-GNB, and further dem-
onstrating the transfer of CR-GNB isolates in ICUs. Our study suggests that effective
infection control measures are required to limit the spread of CR-GNB within hospi-
tals.
KEYWORDS carbapenem, Gram-negative bacteria, colonization, acquisition, risk
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Carbapenem-resistant (CR) Gram-negative bacteria (GNB), such as Enterobacteria-ceae, Acinetobacter baumannii, and Pseudomonas aeruginosa, are challenges in the
management of high-risk patients, e.g., intensive care unit (ICU) patients, particularly in
low- and middle-income countries. Several mechanisms, including alteration of outer
membranes, efﬂux pump overexpression, and production of carbapenemases, contrib-
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ute to carbapenem resistance (1). The last mechanism is worrisome, as genes encoding
carbapenemases often reside on mobile genetic elements, facilitating their spread
among bacterial pathogens. Several types of carbapenemases have been reported,
including serine-type enzymes (KPC, OXA-48) and metallo--lactamases (NDM, IMP,
VIM) (1).
CR-GNB frequently show resistance to other antibiotic classes, such as aminoglyco-
sides and quinolones, limiting therapeutic options. Infections with CR-GNB among
patients in ICUs can be associated with increases in the severity of illness, costs of
treatment, length of stay, and mortality (2). The incidence of CR-GNB infection varies,
depending on the region and the patient population. In Thailand, infections caused by
CR A. baumannii and CR P. aeruginosa are frequently reported, and this is particularly
the case for A. baumannii, which is regarded as a key pathogen in Thailand. However,
those caused by CR Enterobacteriaceae are not so common (3). Recently, data from the
National Antimicrobial Resistance Surveillance Thailand (NARST) from January 2017 to
December 2017 showed that 70% and 20% of Acinetobacter calcoaceticus-A. baumannii
complex and P. aeruginosa isolates, respectively, were resistant to meropenem. In
contrast, the rate of carbapenem resistance in Enterobacteriaceae remains low. For
instance, the prevalence of resistance to imipenem and meropenem in Escherichia coli
was approximately 2.5% (http://narst.dmsc.moph.go.th/).
Intestinal colonization with CR-GNB at the time of ICU admission has been shown to
be associated with an increased risk of subsequent CR-GNB infections and high
mortality rates (4, 5). Furthermore, ICU patients who are positive for carriage on
admission may act as a reservoir for further dissemination in ICUs (6). Additionally, the
clonal spread of CR-GNB and the horizontal transfer of carbapenemase genes among
Gram-negative bacteria within hospitals have previously been reported (7–9). Low
CR-GNB carriage rates were reported from South Korea (0.3%) (10) and France (2.1%)
(11), whereas those from China and Greece were higher (6.5 to 12.8%) (12, 13).
However, the fecal carriage rates of CR-GNB among patients admitted to ICUs in India
and Iran were as high as 35 to 37% (14, 15).
Since therapeutic options for CR-GNB infections are limited, infection control mea-
sures, such as contact isolation, cleaning and disinfection of medical devices, as well as
antibiotic stewardship programs, have become increasingly important to minimize
their spread. Previous studies have shown that routine surveillance for CR-GNB in rectal
swab specimens on admission contributes to a signiﬁcant reduction in CR-GNB infec-
tions during ICU stays (16, 17). However, data on the rate of colonization with CR-GNB
among hospitalized patients in Thai hospitals are very limited. This study was con-
ducted to assess the prevalence of and risk factors for intestinal colonization and
acquisition of CR-GNB among patients admitted to ICUs.
RESULTS
Characteristics of studied ICU patients. During the study period, 2,652 patients
were admitted to ICUs (2,345 from Buddhachinaraj Hospital [BUH] and 307 from
Naresuan University Hospital [NUH]). Of these, 275 ICU patients (213 and 62 from BUH
and NUH, respectively) agreed to participate in this study (Fig. 1). The patient median
age was 63 years (range, 20 to 97 years), and 54.2% were male. The median length of
ICU stay was 6 days (range, 2 to 43 days). The most common reason for ICU admission
was respiratory tract disease (25.1%), followed by cardiovascular disease (12.7%). The
majority of patients were admitted to an ICU directly from home (36.0%). The most
common underlying condition was cardiovascular disease (47.3%). The patients’ char-
acteristics are shown in Table 1.
Prevalence of and risk factors for intestinal colonization with CR-GNB among
ICU patients at admission. Of the 275 patients, 32 patients carried CR-GNB (11.6%,
95% conﬁdence interval [CI]  8.1 to 16.0%); 10.8% (23/213) were from BUH and 14.5%
(9/62) were from NUH (Fig. 1). Twenty-eight patients carried a single CR-GNB isolate.
Two different CR-GNB species were detected in 3 patients, and 3 different species were
simultaneously isolated from 1 patient. Overall, 37 CR-GNB isolates were recovered, and
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the predominant species was A. baumannii (n  15, 40.5%), followed by Klebsiella
pneumoniae (n  9, 24.3%), Acinetobacter spp. (n  5, 13.5%), and Enterobacter spp.
(n  3, 8.1%) (Table 2).
Among the 37 CR-GNB isolates, 26 isolates from 26 different patients were
carbapenemase-producing GNB (CP-GNB), resulting in a prevalence of CP-GNB carriage
of 9.5% (26/275, 95% CI  6.3 to 13.5%). The majority of CP-GNB isolates were
blaOXA-positive A. baumannii isolates (n  14), which possessed a variety of OXA-
carbapenemase genes, mostly blaOXA-23/51. blaNDM was found in K. pneumoniae, Entero-
bacter spp., and A. baumannii. One A. baumannii isolate was positive for blaIMP (Table 2).
The patients’ characteristics and history were analyzed to identify risk factors
associated with intestinal colonization with CR-GNB. Using univariate analysis, CR-GNB
colonization was associated with antibiotic usage within the previous 3 months,
hospitalization within the previous 6 months, and prior respiratory tract disease.
However, with multiple logistic regression analysis, hospitalization within the previous
6 months was the only risk factor associated with CR-GNB colonization (P  0.002,
adjusted odds ratio [aOR]  3.818, 95% CI  1.642 to 8.878) (Table 1).
Among the 32 patients who were colonized with CR-GNB, 6 patients developed
infections during their ICU stays. However, clinical infection due to CR-GNB was found in
only 1 patient (3.13%). This patient was a CR A. baumannii carrier at ICU admission, further
developed a pulmonary infection caused by CR A. baumannii on the 4th day in the ICU, and
was discharged alive after 11 days in the ICU. Other causes of clinical infections included
extended-spectrum -lactamase (ESBL)-producing K. pneumoniae (n  1), K. pneumoniae
(n  1), Enterobacter aerogenes (n  1), Elizabethkingia meningoseptica (n  1), and a
combination of P. aeruginosa and Enterococcus spp. (n  1).
Prevalence of and risk factors for CR-GNB acquisition during ICU stay. At
discharge, we were able to obtain rectal swab specimens from 206 patients. Fifty-two
patients acquired CR-GNB isolates, leading to an overall acquisition incidence of 25.2%
(52/206, 95% CI  19.5 to 31.7%), with the acquisition incidence being 24.8% (36/145)
at BUH and 26.2% (16/61) at NUH (Fig. 1). In 52 acquisition cases, 43 patients were
negative for CR-GNB carriage at admission screening. Only 9 patients who were already
a carrier upon admission acquired an additional CR-GNB isolate during their ICU stay.
A total of 59 CR-GNB isolates were recovered. The most common species was A.
baumannii (n  28, 47.5%), followed by K. pneumoniae (n  13, 22.0%), Acinetobacter
spp. (n  7, 11.9%), and P. aeruginosa (n  5, 8.5%) (Table 2).
Among the 59 CR-GNB isolates, 27 isolates from 27 different patients were CP-GNB,
resulting in an overall CP-GNB acquisition rate of 13.1% (27/206, 95% CI 8.8 to 18.5%).
FIG 1 Flowchart of patients included in this study. CR-GNB, carbapenem-resistant Gram-negative bac-
teria; ICU, intensive care unit; BUH, Buddhachinaraj Hospital; NUH, Naresuan University Hospital.
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The most common CP-GNB was blaOXA-23/51-positive A. baumannii (n 15), followed by
blaNDM-positive K. pneumoniae (n  9). Three P. aeruginosa isolates were positive for
blaIMP.
Univariate analysis and ﬁnal multiple logistic regression analysis showed that the
use of an enteral feeding tube (P  0.008, aOR  5.386, 95% CI  1.563 to 18.564) and
administration of third-generation cephalosporins (P  0.032, aOR  2.293, 95% CI 
1.074 to 4.896) and carbapenems (P  0.045, aOR  2.199, 95% CI  1.019 to 4.743)
were signiﬁcantly associated with CR-GNB acquisition the during ICU stay (Table 3).
Patient-to-patient transmission. All 52 patients who acquired CR-GNB during their
ICU stay were considered at a possible risk of patient-to-patient transmission. Fifty-one
and 15 isolates of CR Acinetobacter spp. and CR K. pneumoniae, respectively, were
available for genotypic studies. Pulsed-ﬁeld gel electrophoresis (PFGE) analysis of
Acinetobacter spp. and K. pneumoniae isolates revealed 31 and 9 different proﬁles,
respectively (see Fig. S1 and S2 in the supplemental material). Among these, 5 and 2
PFGE proﬁles from Acinetobacter spp. and K. pneumoniae, respectively, were found to
contain 1 isolate. However, the majority of isolates which shared identical or similar
PFGE proﬁles were recovered from patients admitted to an ICU across various time
points. Thus, patient-to-patient transmission was unlikely (Table S1).
TABLE 1 Factors associated with intestinal colonization of CR-GNB among ICU patientse
Characteristic
No. (%) of patients in the following groups with the
indicated characteristic:
Univariate
analysis
P value
Multivariate logistic
regression analysis
All patients
(n  275)
CR-GNB carriers
(n  32)
Non-CR-GNB carriers
(n  243) P valuea aOR (95% CI)
Male patients 149 (54.2) 14 (43.8) 135 (55.6) 0.199
Age 65 yr 119 (43.3) 16 (50.0) 103 (42.4) 0.497
Secondary school educationb 190 (69.1) 19 (59.4) 171 (70.4) 0.174
5 family membersc 52 (18.9) 4 (12.5) 48 (19.8) 0.381
Family income of 10,000 bahtd 168 (61.1) 18 (56.3) 150 (61.7) 0.405
Urban living 85 (30.9) 11 (34.4) 74 (30.5) 0.520
Antibiotic usage within previous 3 mo 93 (33.8) 17 (53.1) 76 (31.3) 0.017 0.278 1.614 (0.679–3.836)
Hospitalization within previous 6 mo 89 (32.4) 19 (59.4) 70 (28.8) 0.001 0.002 3.818 (1.642–8.878)
Referral of patients from:
Home 99 (36.0) 10 (31.3) 89 (36.6) 0.722
Another hospital 73 (26.5) 7 (21.9) 66 (27.2) 0.654
Another ward within hospital 92 (33.5) 12 (37.5) 80 (32.9) 0.434
Principle diagnosis
Respiratory tract disease 69 (25.1) 13 (40.6) 56 (23.0) 0.034 0.051 2.309 (0.996–5.353)
Cardiovascular disease 35 (12.7) 6 (18.8) 29 (11.9) 0.271
Renal disease 19 (6.9) 3 (9.4) 16 (6.6) 0.477
Sepsis 41 (14.9) 4 (12.5) 37 (15.2) 0.797
Underlying condition
Cardiovascular disease 130 (47.3) 14 (43.8) 116 (47.7) 0.665
Diabetes 71 (25.8) 11 (34.4) 60 (24.7) 0.233
Respiratory tract disease 35 (12.7) 6 (18.8) 29 (11.9) 0.264
Renal disease 38 (13.8) 5 (15.6) 33 (13.6) 0.784
Liver disease 18 (6.5) 1 (3.1) 17 (7.0) 0.704
Length of ICU stay (day)
8 days 165 (60.0) 17 (53.1) 148 (60.9) 0.274
8–14 days 51 (14.5) 7 (21.9) 44 (18.1) 0.666
15–21 days 29 (10.5) 5 (15.6) 24 (9.9) 0.362
21 days 14 (5.1) 2 (6.3) 12 (4.9) 0.678
30-day mortality 35 (12.7) 4 (12.5) 31 (12.8) 1.000
aA P value of 0.05 was considered statistically signiﬁcant.
bBasic education in Thailand consists of 6 years of primary school education and 6 years of secondary school education.
cAverage number of household members.
dThe average minimum income per month is 10,000 baht.
eData are for a total of 275 patients.
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Nevertheless, we found three cases of patient-to-patient transmission (Table S1). In
the ﬁrst case, the patient acquired a CR A. baumannii isolate which was previously
found in another patient who had been admitted to the ICU 7 days earlier. The A.
baumannii isolates showed closely related PFGE patterns (only one band difference)
(Fig. S1) and identical antimicrobial resistance patterns, indicating that these were the
same strain. Moreover, the two patients were placed in adjacent beds, and their ICU
stays overlapped by 6 days.
The second case of patient-to-patient transmission involved a patient who acquired
a CR A. baumannii isolate from another patient who had been admitted to the ICU 2
days earlier. The two A. baumannii isolates showed identical PFGE proﬁles and identical
antimicrobial resistance proﬁles, and the patient ICU stays overlapped by 6 days,
conﬁrming patient-to-patient transmission (Table S1 and Fig. S1).
In the third example, the patient acquired a CR K. pneumoniae isolate which had
previously been found in another patient who was admitted to the ICU during the same
period of time. The PFGE and antimicrobial resistance patterns of the 2 isolates were
identical, and the ICU stays overlapped by 2 days (Table S1 and Fig. S2).
DISCUSSION
Intestinal colonization with CR-GNB among ICU patients is a major threat for
hospitalized patients, as the colonized patients serve as a reservoir for the dissemina-
tion of CR-GNB in hospital settings (6, 7). Screening of rectal swab specimens for
CR-GNB carriage at the time of ICU admission may help to identify patients who require
isolation or who are at high risk of developing endogenous infections and require
frequent monitoring during their ICU stay. CR-GNB colonization among patients ad-
mitted to an ICU has previously been studied, and various carriage rates have been
reported (10–15). In the present study, we found that 11.6% and 9.5% of patients
admitted to ICUs were colonized with CR-GNB and CP-GNB, respectively. During their
ICU stays, these patients acquired CR-GNB and CP-GNB at rates of 25.2% and 13.1%,
respectively. The relatively high rate of CR-GNB acquisition implies that infection
control measures may not be optimal, contributing to the spread of carbapenem-
resistant organisms in ICUs.
Species identiﬁcation revealed that the most common CR-GNB was A. baumannii,
followed by K. pneumoniae, in the carriage and acquisition groups. Molecular charac-
terization of carbapenemase genes showed that blaOXA (blaOXA-23, blaOXA-24, blaOXA-51,
and blaOXA-58) was commonly found in A. baumannii, consistent with the fact that
TABLE 2 Distribution of CR-GNB isolates and types of carbapenemase genes among CR-GNB in carriage and acquisition groups
Organism
No.
(%) of
isolates
No. of isolates carrying the following carbapenemase gene:
blaIMP blaNDM blaOXA-23 blaOXA-24 blaOXA-51 blaOXA-58 blaOXA-23/51 blaOXA-51/58 blaOXA-23/51/58 blaOXA-24/51/58
CR-GNB carriage
isolates
37
A. baumannii 15 (40.5) 1 1 2 1 2 5 1 3
K. pneumoniae 9 (24.3) 6
Acinetobacter spp. 5 (13.5) 1 1
Enterobacter spp. 3 (8.1) 2
Other CR-GNBa 5 (13.5)
CR-GNB acquisition
isolates
59
A. baumannii 28 (47.5) 4 15 3 2 1
K. pneumoniae 13 (22.0) 9
Acinetobacter spp. 7 (11.9) 2 1 1
P. aeruginosa 5 (8.5) 3
Enterobacter spp. 1 (1.7) 1
Klebsiella spp. 1 (1.7) 1
Other CR-GNBb 4 (6.8)
aOther CR-GNB isolates included P. aeruginosa (n  2), Escherichia coli (n  1), Serratia marcescens (n  1), and Citrobacter freundii (n  1).
bOther CR-GNB isolates included Klebsiella oxytoca (n  2), Serratia spp. (n  1), and Shigella spp. (n  1).
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carbapenem resistance in Acinetobacter spp. is often associated with the production of
OXA-type carbapenemases (18). blaNDM was mainly found in K. pneumoniae, which is in
good agreement with previous reports from countries in Southeast Asia, such as
Singapore and Malaysia, where blaNDM-positive K. pneumoniae is prevalent among
CR-GNB (19, 20). blaNDM and blaIMP were found in other GNB, such as Acinetobacter spp.,
P. aeruginosa, and Enterobacter spp., although blaIMP was observed more frequently in
P. aeruginosa. The presence of blaOXA-, blaIMP-, and blaNDM-positive isolates in a
patient’s intestinal tract is of concern since these genes are commonly associated with
a transmissible plasmid; thus, they can be readily transferred to other intestinal ﬂora
(21, 22). It should be noted that 8 patients were colonized with Stenotrophomonas
maltophilia. However, carbapenem resistance in S. maltophilia is intrinsic since it
possesses a chromosomally encoded metallo--lactamase. S. maltophilia rarely causes
serious disease. Additionally, it is not common among clinically important Gram-
negative bacteria; therefore, S. maltophilia was not further investigated. In addition, we
TABLE 3 Factors associated with acquisition of CR-GNB among patients during ICU stayc
Characteristic
No. (%) of patients in the following groups with the
indicated characteristic:
Univariate
analysis
P value
Multivariate logistic regression
analysis
All patients
(n  206)
CR-GNB acquisition
(n  52)
Non-CR-GNB acquisition
(n  154) P valuea aOR (95% CI)
Male gender 113 (54.9) 30 (57.7) 83 (53.9) 0.540
Age 65 yr 84 (40.8) 23 (44.2) 61 (39.6) 0.486
Mechanical devices
Central venous catheter 29 (14.1) 8 (15.4) 21 (13.6) 0.690
Indwelling urinary catheter 168 (81.6) 43 (82.7) 125 (81.2) 0.485
Enteral feeding tube 153 (74.3) 46 (88.5) 107 (69.5) 0.002 0.008 5.386 (1.563–18.564)
Endotracheal tube 159 (77.2) 46 (88.5) 113 (73.4) 0.007 0.729 0.763 (0.165–3.527)
Antibiotic usage during ICU stay
First- and second-generation
cephalosporins
35 (17.0) 6 (11.5) 29 (18.8) 0.258
Third-generation
cephalosporins
121 (58.7) 37 (71.2) 84 (54.5) 0.017 0.032 2.293 (1.074–4.896)
Carbapenems 42 (20.4) 16 (30.8) 26 (16.9) 0.023 0.045 2.199 (1.019–4.743)
Penicillinsb 4 (1.9) 2 (3.8) 2 (1.3) 0.254
-Lactam–-lactamase
inhibitors
36 (17.5) 10 (19.2) 26 (16.9) 0.629
Aminoglycosidesb 2 (1.0) 1 (1.9) 1 (0.6) 0.433
Fluoroquinolones 18 (8.7) 7 (13.5) 11 (7.1) 0.156
Macrolides 26 (12.6) 8 (15.4) 18 (11.7) 0.437
Colistinb 7 (3.4) 2 (3.8) 5 (3.2) 0.682
Vancomycin 11 (5.3) 4 (7.7) 7 (4.5) 0.470
Clindamycin 21 (10.2) 4 (7.7) 17 (11.0) 0.531
Metronidazole 12 (5.8) 5 (9.6) 7 (4.5) 0.174
Fosfomycinb 2 (1.0) 1 (1.9) 1 (0.6) 0.433
Underlying conditions
Cardiovascular disease 97 (47.1) 23 (44.2) 74 (48.1) 0.870
Respiratory disease 25 (12.1) 7 (13.5) 18 (11.7) 0.635
Renal disease 24 (11.7) 8 (15.4) 16 (10.4) 0.264
Diabetes 52 (25.2) 14 (26.9) 38 (24.7) 0.592
Liver disease 14 (6.8) 2 (3.8) 12 (7.8) 0.524
Length of ICU stay (day)
8 days 129 (62.6) 24 (46.2) 105 (68.2) 0.008 0.498 0.730 (0.293–1.815)
8–14 days 34 (16.5) 10 (19.2) 24 (15.6) 0.449
15–21 days 22 (10.7) 9 (17.3) 13 (8.4) 0.055 0.131 2.144 (0.797–5.767)
21 days 8 (3.9) 4 (7.7) 4 (2.6) 0.100 0.149 3.227 (0.657–15.860)
30-day mortality 16 (7.8) 5 (9.6) 11 (7.1) 0.553
aA P value of 0.05 was considered statistically signiﬁcant.
bThe rate of use was too low to give an accurate P value.
cData are for a total of 206 patients.
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identiﬁed several isolates of CR-GNB which were carbapenemase negative (Table 2).
Carbapenem resistance in these organisms may result from efﬂux pump overexpression
or alterations in the outer membrane protein (1). For Enterobacteriaceae, carbapenem
resistance may be caused by a combination of AmpC or ESBL production with porin
defects (1).
Multivariate logistic regression analysis showed that hospitalization within the
previous 6 months was strongly associated with CR-GNB carriage upon ICU admission
(Table 1), similar to the ﬁndings of previous studies in China and Greece (12, 13). This
ﬁnding is not totally unexpected, as a previous hospitalization could expose patients to
resistant bacteria in the hospital, which might contribute to subsequent CR-GNB
colonization.
The relatively high rate of acquiring CR-GNB during an ICU stay could be due to the
transmission of CR-GNB between patients via health care workers, ICU environments
(inanimate objects/surfaces), or medical devices, since GNB can survive for a long
period of time in the environment (23). These explanations were supported by several
studies from different countries, including Thailand, which showed that CR-GNB isolates
from colonized or infected patients were clonally related to those present on medical
devices or in hospital environments (24–26). In our study, one of the risk factors for
acquiring CR-GNB during an ICU stay was the use of an enteral feeding tube (Table 3),
similar to the ﬁndings of a recent study by Yamamoto et al., who reported that the use
of an enteral feeding tube was signiﬁcantly associated with carbapenem-resistant
Enterobacteriaceae carriage among hospitalized patients in Japan (27). It is possible that
the use of an enteral feeding tube provides a convenient way for CR-GNB organisms to
enter the patient’s intestinal tract, leading to CR-GNB acquisition.
Administration of antibiotics within an ICU could play an important role in CR-GNB
acquisition (2). Our study identiﬁed the use of third-generation cephalosporins and
carbapenems to be independent risk factors for acquiring CR-GNB during an ICU stay
(Table 3), consistent with the ﬁndings of previous studies (11, 28, 29). This could be due
to the selective pressure of the use of antibiotics on the patient’s intestinal ﬂora, which
corresponded to the previous ﬁnding of the inappropriate use of antibiotics in Thai
hospitals (30).
Since the intestinal tract is considered an important reservoir for CR-GNB that may
result in endogenous infections, many studies have suggested that identiﬁcation of
colonized patients and subsequent patient isolation in a single room should be
performed to prevent the spread of CR-GNB within hospitals (6, 16). However, screening
of rectal swab specimens and isolation of colonized patients may not be possible for
resource-constrained countries, like Thailand. Furthermore, among the 52 acquisition
cases, we observed only 3 cases of possible patient-to-patient transmission. Therefore,
infection control measures, such as hand hygiene and proper cleaning and disinfection
of medical devices, may be adequate to negate the dissemination of CR-GNB and
reduce the acquisition rates of CR-GNB within ICUs. These procedures have been
effectively used to reduce the number of cases of CR-GNB infection and colonization in
ICUs in several countries, including Thailand (31–33).
Previous studies revealed that patients who are CR-GNB carriers have a higher
mortality rate than noncarriers (4, 5). In our study, however, we found no signiﬁcant
differences in terms of mortality rates between patients who were colonized with or
acquired CR-GNB and noncarriage or nonacquisition groups. These observations were
consistent with those previously reported in Israel and China (7, 12). However, we noted
that the lengths of ICU stay among patients who were CR-GNB carriers or who acquired
CR-GNB were longer than those among noncarriage or nonacquisition groups, al-
though these were not statistically signiﬁcantly different (Tables 1 and 3).
Our study has some limitations. First, we did not collected samples from hospital
environments (sink, bed, table, etc.), health care workers, or medical devices. Investi-
gation of CR-GNB contamination in these sources might be useful to explain the
relatively high CR-GNB acquisition rate during an ICU stay in our study. Second, we did
not perform risk factor analysis for Enterobacteriaceae and nonfermenters (such as
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Acinetobacter spp. and P. aeruginosa) separately, as the number of CR-GNB isolates was
relatively small. Third, we used meropenem-containing agar for the screening of
CR-GNB, and so some carbapenemase-producing Enterobacteriaceae isolates with low
MICs to meropenem may have been missed. Thus, the prevalence of CR-GNB carriage
and acquisition could have been underestimated. Fourth, this study was conducted in
two hospitals, which may not accurately represent the situation of CR-GNB carriage and
acquisition in Thai hospitals. Despite these limitations, our study provides insight into
the prevalence of and risk factors for CR-GNB carriage at ICU admission and acquisition,
which has important implications for the prevention of CR-GNB dissemination in Thai
hospitals.
In conclusion, our study is the ﬁrst Indochinese study reporting the prevalence of
and risk factors for CR-GNB colonization and acquisition among ICU patients as well as
demonstrating the transfer of CR-GNB isolates in ICUs. A relatively high acquisition rate
highlights the need for more effective infection control measures, including hand
hygiene, cleaning and disinfection of medical devices and ICU environments, as well as
antibiotic stewardship programs, to limit the spread of CR-GNB within hospitals.
MATERIALS AND METHODS
Study settings and ethical statement. This observational study was prospectively conducted in the
ICUs of two tertiary care hospitals, the 1,000-bed Buddhachinaraj Hospital (BUH) and the 400-bed
Naresuan University Hospital (NUH), located in Phitsanulok Province, northern Thailand. The present
study was approved by the Naresuan University Institutional Review Board (COA no. 130/2013). Written
informed consent was obtained from the relatives of the patients participating in the study.
Rectal swab sampling and data collection. From December 2014 to December 2015, a total of 275
ICU patients aged 20 years participated in this study. Rectal swab specimens were collected from each
patient within 48 h of ICU admission and at the time of discharge. The collection of samples from the
same patients readmitted during the study period and patients who had diarrhea were excluded.
Microbiological analysis was carried out within 24 h.
The demographic characteristics of the patients were obtained using a questionnaire and interviews
with the patients’ relatives. Clinical proﬁles were obtained from the patient’s medical record. The
following data were collected: age, gender, education, occupation, the number of family members, place
of living, income, underlying conditions, principal diagnosis, previous antibiotic usage, and history of
hospitalization.
Microbiological analysis. Rectal swab samples were directly cultured on Chrome UTI agar (Oxoid,
Basingstoke, UK) supplemented with 25 g/ml vancomycin and 0.5 g/ml meropenem and incubated
under aerobic condition for 24 h at 37°C. Colonies of different morphologies were selected and
subcultured onto tryptic soy agar for further studies. Species identiﬁcation was performed by using a
RapID One system (Remel Inc., KS, USA), in accordance with the manufacturer’s instruction. Isolates that
showed doubtful results were further identiﬁed by ampliﬁcation and sequencing of the 16S rRNA gene
using previously published primers and conditions (34). Identiﬁcation of Acinetobacter spp. to the species
level was performed by multiplex PCR as described previously (35).
All isolates were subjected to testing for susceptibility to carbapenems (imipenem, meropenem, and
ertapenem) by the disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI)
protocols, and the results were interpreted according to CLSI criteria (36). Isolates that showed resistance
to either imipenem, meropenem, or ertapenem were considered CR-GNB.
Molecular studies. All CR-GNB isolates were screened for the presence of carbapenemase genes, i.e.,
blaKPC, blaOXA-48, blaVIM, blaNDM, and blaIMP (37) and blaOXA-23, blaOXA-24, blaOXA-51, and blaOXA-58 (38), by
PCR using speciﬁc primers, as previously described. The PCR mixture consisted of 1 l template DNA, 1
PCR buffer, 0.2 mM deoxynucleoside triphosphates, 0.5 M each primer, and 1 U of Taq polymerase in
a total volume of 25 l. PCRs consisted of predenaturation at 95°C for 7 min, followed by 30 cycles of
95°C for 30 s, 52°C (48°C for blaKPC, blaOXA-48, and blaVIM) for 1 min, and 72°C for 1 min and a ﬁnal
extension at 72°C for 10 min. PCR products were analyzed by agarose gel electrophoresis. Selected PCR
products were puriﬁed and sequenced.
Genotypic characterizations of CR Acinetobacter spp. and CR K. pneumoniae isolates were performed
by pulsed-ﬁeld gel electrophoresis (PFGE). Brieﬂy, a chromosomal DNA plug was prepared and digested
with XbaI (K. pneumoniae) and ApaI (Acinetobacter spp.) (Fermentas Inc, Hanover, MD, USA) as previously
described (39). Electrophoresis was performed in 1% pulsed-ﬁeld-certiﬁed agarose in 0.5 Tris-borate-
EDTA buffer using a contour-clamped homogeneous electric ﬁeld Mapper XA system (Bio-Rad Labora-
tories, CA, USA). The gels were run at 6.0 V/cm with an angle of 120 degrees at 14°C for 20 h.
Saccharomyces cerevisiae chromosomal DNA (Bio-Rad Laboratories) was used as a molecular size stan-
dard. DNA proﬁles were analyzed visually and interpreted according to the criteria of Tenover et al. (40).
Deﬁnitions. CR-GNB colonization was deﬁned as a positive CR-GNB screening result at admission.
CR-GNB acquisition was deﬁned as (i) a negative ﬁrst screening result at admission with a positive one
at discharge or (ii) a positive screening result at admission and a positive one with different CR-GNB
isolates at discharge. In all cases, the ICU stay had to have been at least 48 h.
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For all acquisition cases, we employed the following criteria to determine whether the CR-GNB isolate
was acquired as a result of patient-to-patient transmission: (i) the genotypes of the isolates were identical
on the basis of their PFGE proﬁles, and (ii) the isolates were transmitted from known carriers who had
an overlapping ICU stay with the recipient patient. An overlapping stay was deﬁned as the coexistence
of both carrier and recipient patient for at least 2 days.
Statistical analysis. Statistical analysis was performed using SPSS (version 17) software (SPSS Inc.,
Chicago, IL, USA). Univariate analysis was performed using the chi-square or the Fisher exact test, when
appropriate, for categorical variables. Variables selected by univariate analysis (P  0.1) were included in
multivariate logistic regression analysis using a backward stepwise procedure. All statistical tests were
two-tailed, and a P value of 0.05 was considered statistically signiﬁcantly different. Results are
presented as the adjusted odd ratios (aOR) and 95% conﬁdence intervals (CI).
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